文献速递中毒与环境急症消化、代谢与肾脏急症

医疗补助扩展与阿片类药物相关住院使用率之间的关联

Association Between Medicaid Expansion and Rates of Opioid-Related Hospital Use.
PubMed 文献 · JAMA Intern Med · 2020-01-01
一句话结论观察性研究显示,2014年后实施的医疗补助扩展与阿片类药物相关住院率降低9.74%相关(95%CI -18.83%至-0.65%),而与急诊就诊率无显著关联。

该研究采用双重差分观察性设计,比较2005年第一季度至2017年第四季度间实施医疗补助扩展的州与未扩展州在阿片类药物相关急诊就诊和住院方面的变化,数据来自45个州HCUP FastStats的全付费方出院记录。结果显示,2014年后医疗补助扩展与阿片类药物相关住院率降低9.74%(95%CI -18.83%至-0.65%)相关;2014年前或2014年后的医疗补助扩展与阿片类药物相关急诊就诊率均无显著关联。作者认为医疗补助扩展似乎与阿片类药物相关住院使用的有意义的减少相关,可能归因于其他场所对阿片类药物使用障碍的照护改善。

要点

  • 2014年后医疗补助扩展与阿片类药物相关住院率降低9.74%相关(95%CI -18.83%至-0.65%)。
  • 2014年后医疗补助扩展与阿片类药物相关急诊就诊率无显著关联(-3.98%,95%CI -14.69%至6.72%)。
  • 2014年前医疗补助扩展与阿片类药物相关急诊就诊率亦无显著关联(1.02%,95%CI -5.25%至7.28%)。
  • 研究为观察性双重差分设计,纳入45个州HCUP FastStats的全付费方出院数据。
  • 作者认为住院使用减少可能归因于其他场所对阿片类药物使用障碍照护的改善。

适用人群与场景

  • 美国非联邦、非康复医院中所有付费方的急诊及住院出院记录,来自45个州HCUP FastStats。

研究设计与关键结果

  • 研究设计为双重差分观察性设计,比较2005年第一季度至2017年第四季度间实施医疗补助扩展的州与未扩展州的变化。
  • 共分析46个州及哥伦比亚特区的1524条急诊科数据观察值和2219条阿片类药物相关住院观察值。
  • 2014年后医疗补助扩展与阿片类药物相关住院率降低9.74%相关(95%CI -18.83%至-0.65%)。
  • 2014年后医疗补助扩展与阿片类药物相关急诊就诊率无显著关联(-3.98%,95%CI -14.69%至6.72%)。
  • 2014年前医疗补助扩展与阿片类药物相关急诊就诊率无显著关联(1.02%,95%CI -5.25%至7.28%)。

证据类型、等级与局限

  • 证据类型:观察性双重差分研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为医疗补助扩展似乎与阿片类药物相关住院使用的有意义的减少相关,可能归因于其他场所对阿片类药物使用障碍照护的改善。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: The rate of opioid-related emergency department (ED) visits and inpatient hospitalizations has increased rapidly in recent years. Medicaid expansions have the potential to reduce overall opioid-related hospital events by improving access to outpatient treatment for opioid use disorder.

OBJECTIVE: To examine the association between Medicaid expansions and rates of opioid-related ED visits and inpatient hospitalizations.

DESIGN, SETTING, AND PARTICIPANTS: A difference-in-differences observational design was used to compare changes in opioid-related hospital events in US nonfederal, nonrehabilitation hospitals in states that implemented Medicaid expansions between the first quarter of 2005 and the last quarter of 2017 with changes in nonexpansion states. All-payer ED and hospital discharges from 45 states in the Healthcare Cost and Utilization Project FastStats were included.

EXPOSURES: State implementation of Medicaid expansions between 2005 and 2017.

MAIN OUTCOMES AND MEASURES: Rates of all opioid-related ED visits and inpatient hospitalizations, measured as the quarterly numbers of treat-and-release ED discharges and hospital discharges related to opioid abuse, dependence, and overdose, per 100 000 state population.

RESULTS: In the 46 states and District of Columbia included in the study, 1524 observations of emergency department data and 2219 observations of opioid-related inpatient hospitalizations were analyzed. The post-2014 Medicaid expansions were associated with a 9.74% (95% CI, -18.83% to -0.65%) reduction in the rate of opioid-related inpatient hospitalizations. There appeared to be no association between the pre-2014 or post-2014 Medicaid expansions and the rate of opioid-related ED visits (post-2014 Medicaid expansions, -3.98%; 95% CI, -14.69% to 6.72%; and pre-2014 Medicaid expansions, 1.02%; 95% CI, -5.25% to 7.28%).

CONCLUSIONS AND RELEVANCE: Medicaid expansion appears to be associated with meaningful reductions in opioid-related hospital use, possibly attributable to improved care for opioid use disorder in other settings.

来源:JAMA Intern Med,查看原文。版权归原作者所有。

参考来源

  1. Wen H, Soni A, Hollingsworth A, et al. Association Between Medicaid Expansion and Rates of Opioid-Related Hospital Use. JAMA Intern Med. 2020. PMID: 32202609. doi:10.1001/jamainternmed.2020.0473

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。